Drug Profile
Plague vaccine - Altimmune
Alternative Names: Recombinant dual antigen vaccine for plague - Altimmune; Recombinant Yersinia pestis vaccine - Altimmune; rYP vaccine - Altimmune; RypVaxLatest Information Update: 05 May 2017
Price :
$50
*
At a glance
- Originator Avecia
- Developer PharmAthene
- Class Plague vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Plague
Most Recent Events
- 04 May 2017 Altimmune merged with PharmAthene and the combined entity was renamed as Altimmune
- 08 Oct 2004 Preclinical trials in Pneumonic plague in United Kingdom (Parenteral)